Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05353478 · ClinicalTrials.gov registry record

Reducing Opioid Prescription After Kidney Stone Removal Surgery

A clinical trial of Kidney Stone, sponsored by Mayo Clinic.

Active
Registry status
80
Enrollment target
1
Study location

NCT05353478 is a study of Kidney Stone that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05353478, a study of Kidney Stone, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to implement and assess a standard way of prescribing opioid pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being discharged with an appropriate quantity of pain management medication.

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-06-06
Est. Completion 2026-08

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05353478

The ClinicalTrials.gov registry entry for NCT05353478 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (58% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 0 interventions.

NCT05353478 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05353478 about?

NCT05353478 is a clinical study titled "Reducing Opioid Prescription After Kidney Stone Removal Surgery". The purpose of this study is to implement and assess a standard way of prescribing opioid pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being discharged with an appropriate quantity of pain management medication.

What is the current status of trial NCT05353478?

This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2022-06-06. Estimated completion is 2026-08.

What conditions does trial NCT05353478 study?

This clinical trial studies the following conditions: Kidney Stone.

Who is sponsoring clinical trial NCT05353478?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05353478 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.